Kansas SB292 prohibits the sale of hemp-derived cannabinoid products to individuals under 21, sets packaging and labeling requirements, and amends.
Kansas SB292 introduces measures to regulate the sale and distribution of hemp-derived cannabinoid products. It prohibits the sale of these products to individuals under the age of 21. The bill also mandates specific packaging and labeling requirements for such products, including the provision of a certificate of analysis, information on the product's origin, and contact details of the manufacturer or distributor.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.